BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT)BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT)BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT)

BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT)

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪256.89 K‬USD
‪11.15 M‬
Beta (1Y)
1.03

About Bellerophon Therapeutics, Inc.


CEO
Craig R. Jalbert
Headquarters
Warren
Founded
2009
FIGI
BBG00JVRN8H3
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0HMP is 0.0400 USD — it has increased by 8.11% in the past 24 hours. Watch BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) stocks are traded under the ticker 0HMP.
0HMP stock has risen by 8.11% compared to the previous week, the month change is a 8.11% rise, over the last year BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) has showed a 26.98% increase.
0HMP reached its all-time high on Jan 30, 2018 with the price of 37.2000 USD, and its all-time low was 0.0315 USD and was reached on Dec 6, 2023. View more price dynamics on 0HMP chart.
See other stocks reaching their highest and lowest prices.
0HMP stock is 7.50% volatile and has beta coefficient of 1.03. Track BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) there?
Today BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) has the market capitalization of ‪256.88 K‬, it has decreased by −27.27% over the last week.
Yes, you can track BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
No, 0HMP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0HMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) stock shows the sell signal. See more of BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.